Refractory cytopenia with multi-lineage dysplasia (Q39432): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Síndrome mielodisplásica caracterizada por bicitopenia ou pancitopenia e alterações displásicas em 10% ou mais das células em duas ou mais linhagens de células mieloides.
description / endescription / en
 
A myelodysplastic syndrome characterised by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1839380478 / rank
 
Normal rank
Property / CURIE
 
CID11:2A34
Property / CURIE: CID11:2A34 / rank
 
Normal rank
Property / Canary Token
 
dki-india-2A34
Property / Canary Token: dki-india-2A34 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: D46.5 / rank
 
Normal rank

Latest revision as of 04:51, 13 August 2026

A myelodysplastic syndrome characterised by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines.
Language Label Description Also known as
default for all languages
2A34
    English
    Refractory cytopenia with multi-lineage dysplasia
    A myelodysplastic syndrome characterised by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines.

      Statements

      CID11:2A34
      0 references
      dki-india-2A34
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references